| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5614473 | Journal of Cardiac Failure | 2017 | 9 Pages |
Abstract
After CRT, a majority of patients are capable of tolerating higher dosages of neurohumoral blockers. Up-titration of neurohumoral blockers after CRT implantation is associated with improved clinical outcomes, similarly to patients treated with the guideline-recommended target dose at the time of CRT implantation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pieter MD, Frederik H. MD, PhD, Petra MD, Philippe B. MD, Msc, PhD, Matthias MD, Wilson H. MD, Wilfried MD, PhD,